PTP1B as a drug target: recent developments in PTP1B inhibitor discovery

S Zhang, ZY Zhang - Drug discovery today, 2007 - Elsevier
Protein tyrosine phosphatase 1B (PTP1B) is an effective target for the treatment of both type
2 diabetes and obesity; however, targeting PTP1B for drug discovery is challenging because …

Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders

S Singh, AS Grewal, R Grover, N Sharma, B Chopra… - Bioorganic …, 2022 - Elsevier
The aim of this review was to discuss an overview of type 2 diabetes; biology of PTP1B; role
of PTP1B in metabolic disorders; and recent updates in the development of PTP1B inhibitors …

Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer

AP Combs - Journal of medicinal chemistry, 2010 - ACS Publications
Many eukaryote cellular functions are regulated by precise control of the phosphorylation
levels of proteins involved in a variety of signal transduction processes. Protein tyrosine …

Tethering: fragment-based drug discovery

DA Erlanson, JA Wells… - Annu. Rev. Biophys …, 2004 - annualreviews.org
▪ Abstract The genomics revolution has provided a deluge of new targets for drug discovery.
To facilitate the drug discovery process, many researchers are turning to fragment-based …

The critical role of passive permeability in designing successful drugs

L Di, P Artursson, A Avdeef, LZ Benet… - …, 2020 - Wiley Online Library
Passive permeability is a key property in drug disposition and delivery. It is critical for
gastrointestinal absorption, brain penetration, renal reabsorption, defining clearance …

An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering

DA Keedy, ZB Hill, JT Biel, E Kang, TJ Rettenmaier… - Elife, 2018 - elifesciences.org
Allostery is an inherent feature of proteins, but it remains challenging to reveal the
mechanisms by which allosteric signals propagate. A clearer understanding of this intrinsic …

Inhibitors of protein tyrosine phosphatases: Next‐generation drugs?

L Bialy, H Waldmann - Angewandte Chemie International …, 2005 - Wiley Online Library
The protein tyrosine phosphatases (PTPs) constitute a family of closely related key
regulatory enzymes that dephosphorylate phosphotyrosine residues in their protein …

The two faces of PTP1B in cancer

L Lessard, M Stuible, ML Tremblay - … et Biophysica Acta (BBA)-Proteins and …, 2010 - Elsevier
PTP1B is a classical non-transmembrane protein tyrosine phosphatase that plays a key role
in metabolic signaling and is a promising drug target for type 2 diabetes and obesity …

The Gewald multicomponent reaction

Y Huang, A Dömling - Molecular diversity, 2011 - Springer
The Gewald reaction of sulfur, cyanoacetic acid derivatives, and oxo-component (G-3CR)
yielding highly substituted 2-aminothiophene derivatives has seen diverse applications in …

Protein tyrosine phosphatases: structure, function, and implication in human disease

L Tautz, DA Critton, S Grotegut - Phosphatase Modulators, 2013 - Springer
Protein tyrosine phosphorylation is a key regulatory mechanism in eukaryotic cell
physiology. Aberrant expression or function of protein tyrosine kinases and protein tyrosine …